Ilsung Pharm (003120) — Capital Reinvestment Ratio
Latest as of June 2025:
0.08x
Ilsung Pharm (003120) has a Capital Reinvestment Ratio of 0.08x as of June 2025, meaning it reinvests 0% of its operating cash flow (₩5.13 Billion) in capital expenditures (₩395.62 Million). See cash generation quality of Ilsung Pharm to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
0.08x
Capex / Operating Cash Flow
Operating Cash Flow
₩5.13 Billion
KRW
Capital Expenditures
₩395.62 Million
KRW
Data as of
Jun 2025
Most recent filing
Ilsung Pharm Capital Reinvestment Ratio (2013–2025)
This chart tracks Ilsung Pharm's Capital Reinvestment Ratio across 9 annual periods.
Annual Capital Reinvestment Ratio for Ilsung Pharm (2013–2025)
Year-by-year Capital Reinvestment Ratio for Ilsung Pharm from 2013 to 2025. For live market cap and broader valuation context, see 003120 market cap.
| Year | Reinvestment Ratio | Operating CF (KRW) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 0.56x | ₩3.88 Billion | ₩2.18 Billion | ▼ -70.7% |
| 2021 | 1.92x | ₩5.70 Billion | ₩10.93 Billion | ▼ -38.1% |
| 2020 | 3.09x | ₩1.56 Billion | ₩4.82 Billion | ▲ +994.5% |
| 2019 | 0.28x | ₩4.39 Billion | ₩1.24 Billion | ▲ +252.7% |
| 2018 | 0.08x | ₩15.09 Billion | ₩1.21 Billion | ▼ -56.0% |
| 2017 | 0.18x | ₩10.16 Billion | ₩1.85 Billion | ▼ -61.4% |
| 2015 | 0.47x | ₩6.04 Billion | ₩2.85 Billion | ▲ +109.0% |
| 2014 | 0.23x | ₩4.19 Billion | ₩945.31 Million | ▲ +1.4% |
| 2013 | 0.22x | ₩5.06 Billion | ₩1.13 Billion | — |
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow